跳至主要内容
临床试验/2023-506031-15-01
2023-506031-15-01招募中2 期

Hypertonic LActaTe afTer cardiac arrEst: the LATTE trial

Hopital Erasme1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2024年9月12日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
125
试验地点
1
主要终点
Neuron specific enolase (NSE) plasmatic peak values at 48 hours after return of spontaneous circulation.

研究概览

简要总结

To evaluate the efficacy of hypertonic sodium lactate infusion to decrease brain injury after cardiac arrest in comatose survivors.

研究设计

分配方式
Randomized
主要目的
Main Trial
盲法
None

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Age > 18 years old
  • Sustained return of spontaneous circulation (ROSC) ≥ 20 minutes
  • Comatose state (Glasgow coma scale - GCS < 9)
  • Time to ROSC > 15'

排除标准

  • Pregnant women
  • Anticipated withdrawal of support within 24 hours
  • Traumatic cause of cardiac arrest
  • Body weight at admission > 120 Kg

结局指标

主要结局

Neuron specific enolase (NSE) plasmatic peak values at 48 hours after return of spontaneous circulation.

Neuron specific enolase (NSE) plasmatic peak values at 48 hours after return of spontaneous circulation.

次要结局

  • Cerebral performance category score of 1 and 1-2 at 90 days.
  • ICU length of stay (days), Hospital length of stay (days).
  • Mortality during ICU stay, during hospital stay, at 90 days.
  • Vasopressor equivalent dose during the first 48h after resuscitation.
  • Seizures episodes during the first 24h, 48h and ICU stay.
  • Peak plasmatic concentrations or neurofilament light chain (NFL) at 24, 48 and 72h.
  • Peak plasmatic concentrations or glial fibrillary acid protein (GFAP) at 24, 48 and 72h
  • Peak plasmatic concentrations or Troponin I (TnI) at 24, 48 and 72h
  • Incidence, nature, and severity of adverse events graded according to National Cancer Institute - Common Terminology Criteria for Adverse Events.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Biomedical research service

Scientific

Hopital Erasme

研究点 (1)

Loading locations...

相似试验